SWOT Analysis for Dr. Lal Pathlabs Ltd. - Strengths

Add SWOT widget to your site/app

Companies with no Debt

Stocks in Buy Zone with High Momentum Score Last Month

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Companies with 10% increase in share price over three months, with rising net profit growth

Companies with high TTM EPS Growth

Expensive Performers (DVM)

PEG lower than Industry PEG

Dividend yield greater than sector dividend yield

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Volume Shockers

Insiders bought stocks

Stocks Outperforming their Industry Price Change in the Quarter

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

Top Losers

Brokers upgraded recommendation or target price in the past three months

Mutual Funds Increased Shareholding in Past Month

Highest FII stock holdings

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Insiders sold stocks

High Piotroski Score - Companies with strong financials

Big Changes up or down in FII holding

Expensive Performers (DVM)

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks